These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 28945015)
1. Membrane Fusion Mediated Intracellular Delivery of Lipid Bilayer Coated Mesoporous Silica Nanoparticles. Yang J; Tu J; Lamers GEM; Olsthoorn RCL; Kros A Adv Healthc Mater; 2017 Oct; 6(20):. PubMed ID: 28945015 [TBL] [Abstract][Full Text] [Related]
2. Lipid bilayer-coated mesoporous silica nanoparticles carrying bovine hemoglobin towards an erythrocyte mimic. Tu J; Bussmann J; Du G; Gao Y; Bouwstra JA; Kros A Int J Pharm; 2018 May; 543(1-2):169-178. PubMed ID: 29567198 [TBL] [Abstract][Full Text] [Related]
3. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery. Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885 [TBL] [Abstract][Full Text] [Related]
4. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA. Li Z; Zhang Y; Zhang K; Wu Z; Feng N Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971 [TBL] [Abstract][Full Text] [Related]
5. Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery. Tu J; Du G; Reza Nejadnik M; Mönkäre J; van der Maaden K; Bomans PHH; Sommerdijk NAJM; Slütter B; Jiskoot W; Bouwstra JA; Kros A Pharm Res; 2017 Aug; 34(8):1693-1706. PubMed ID: 28536970 [TBL] [Abstract][Full Text] [Related]
6. Sub-150 nm mesoporous silica nanoparticles with tunable pore sizes and well-ordered mesostructure for protein encapsulation. Gu J; Huang K; Zhu X; Li Y; Wei J; Zhao W; Liu C; Shi J J Colloid Interface Sci; 2013 Oct; 407():236-42. PubMed ID: 23866201 [TBL] [Abstract][Full Text] [Related]
7. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery. Park HS; Kim CW; Lee HJ; Choi JH; Lee SG; Yun YP; Kwon IC; Lee SJ; Jeong SY; Lee SC Nanotechnology; 2010 Jun; 21(22):225101. PubMed ID: 20453291 [TBL] [Abstract][Full Text] [Related]
8. [Antitumor efficacy of irinotecan-loaded galactosyl modified lipid bilayer-coated mesoporous silica nanoparticles against hepatocellular carcinoma cells]. Chen X; Zhang XX; Li FF; Zhao YN; Jia Z; Gan Y; Li J Yao Xue Xue Bao; 2014 May; 49(5):718-25. PubMed ID: 25151746 [TBL] [Abstract][Full Text] [Related]
9. Chemically reducible lipid bilayer coated mesoporous silica nanoparticles demonstrating controlled release and HeLa and normal mouse liver cell biocompatibility and cellular internalization. Roggers RA; Lin VS; Trewyn BG Mol Pharm; 2012 Sep; 9(9):2770-7. PubMed ID: 22738645 [TBL] [Abstract][Full Text] [Related]
10. PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect. Lin J; Cai Q; Tang Y; Xu Y; Wang Q; Li T; Xu H; Wang S; Fan K; Liu Z; Jin Y; Lin D Int J Pharm; 2018 Jan; 536(1):272-282. PubMed ID: 29079221 [TBL] [Abstract][Full Text] [Related]
11. Hydrolytic surface erosion of mesoporous silica nanoparticles for efficient intracellular delivery of cytochrome c. Choi E; Lim DK; Kim S J Colloid Interface Sci; 2020 Feb; 560():416-425. PubMed ID: 31679782 [TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. Slowing II; Trewyn BG; Lin VS J Am Chem Soc; 2007 Jul; 129(28):8845-9. PubMed ID: 17589996 [TBL] [Abstract][Full Text] [Related]
14. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo. Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575 [TBL] [Abstract][Full Text] [Related]
15. Hypersound-Enhanced Intracellular Delivery of Drug-Loaded Mesoporous Silica Nanoparticles in a Non-Endosomal Pathway. Lu Y; Palanikumar L; Choi ES; Huskens J; Ryu JH; Wang Y; Pang W; Duan X ACS Appl Mater Interfaces; 2019 Jun; 11(22):19734-19742. PubMed ID: 31090387 [TBL] [Abstract][Full Text] [Related]
16. Charge-Selective Delivery of Proteins Using Mesoporous Silica Nanoparticles Fused with Lipid Bilayers. Shi H; Liu S; Cheng J; Yuan S; Yang Y; Fang T; Cao K; Wei K; Zhang Q; Liu Y ACS Appl Mater Interfaces; 2019 Jan; 11(4):3645-3653. PubMed ID: 30609348 [TBL] [Abstract][Full Text] [Related]
17. Novel lipid-coated mesoporous silica nanoparticles loaded with thymoquinone formulation to increase its bioavailability in the brain and organs of Wistar rats. Fahmy HM; Ahmed MM; Mohamed AS; Shams-Eldin E; Abd El-Daim TM; El-Feky AS; Mustafa AB; Abd Alrahman MW; Mohammed FF; Fathy MM BMC Pharmacol Toxicol; 2022 Sep; 23(1):71. PubMed ID: 36163187 [TBL] [Abstract][Full Text] [Related]
18. γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release. Du X; Xiong L; Dai S; Qiao SZ Adv Healthc Mater; 2015 Apr; 4(5):771-81. PubMed ID: 25582379 [TBL] [Abstract][Full Text] [Related]
19. [Preliminary study on pH-sensitive lipid bilayer-coated mesoporous silica nanoparticles as a novel drug carrier for antitumor drug]. Li FF; Zhang XX; Guo SY; Gan Y; Li J Yao Xue Xue Bao; 2013 Feb; 48(2):291-7. PubMed ID: 23672029 [TBL] [Abstract][Full Text] [Related]